T3 N1 M0 rectal cancer: optimal initial management is upfront surgery

被引：0
|
作者：
Harris, Dean A. [1 ,2 ]
机构：
[1] Swansea Bay Univ Hlth Board, Dept Colorectal Surg, Swansea, Wales
[2] Swansea Bay Univ Hlth Board, Dept Colorectal Surg, Swansea SA6B 6NL, Wales
来源：
BRITISH JOURNAL OF SURGERY | 2024年 / 111卷 / 01期
关键词：
RECURRENCE; SURVIVAL; MARGIN;
D O I：
10.1093/bjs/znad321
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [1] T3 N1 M0 rectal cancer: optimal initial management is total neoadjuvant therapy
    Nilsson, Per J.
    [J]. BRITISH JOURNAL OF SURGERY, 2024, 111 (01)
  • [2] T3 N1 M0 rectal cancer: the optimal initial management is long-course chemoradiotherapy
    Arthur, Claire
    Teo, Mark
    [J]. BRITISH JOURNAL OF SURGERY, 2024, 111 (01)
  • [3] Rectal cancer at the crossroads: The dilemma of clinically staged T3, N0,M0 disease
    Kachnic, Lisa A.
    Hong, Theodore S.
    Ryan, David P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (03) : 350 - 351
  • [4] T3N1M0 rectal cancer: the optimal initial management is systemic anti-cancer therapy
    Braun, Michael
    [J]. BRITISH JOURNAL OF SURGERY, 2024, 111 (01)
  • [5] Conservative surgery for T2>3 cm, T3 N0N1 M0 breast cancer after induction chemotherapy
    Bobin, JY
    Zinzindohoue, C
    Virelizier, CF
    Joulai, A
    Khaled, M
    [J]. BULLETIN DU CANCER, 2001, 88 (02) : 175 - 180
  • [6] THE ROLE OF ADJUVANT THERAPY AFTER RESECTION OF T1 N1 M0 AND T2 N1 M0 NON-SMALL CELL LUNG-CANCER
    FERGUSON, MK
    LITTLE, AG
    GOLOMB, HM
    HOFFMAN, PC
    DEMEESTER, TR
    BEVERIDGE, R
    SKINNER, DB
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1986, 91 (03): : 344 - 349
  • [7] A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer
    Stephens, RJ
    Girling, DJ
    Hopwood, P
    Thatcher, N
    [J]. LUNG CANCER, 2005, 49 (03) : 395 - 400
  • [8] TREATMENT OF MODIFIED STAGE-II (T1 N1 M0, T2 N1 M0) NON-SMALL CELL BRONCHOGENIC-CARCINOMA - A COMBINED MODALITY APPROACH
    NEWMAN, SB
    DEMEESTER, TR
    GOLOMB, HM
    HOFFMAN, PC
    LITTLE, AG
    RAGHAVAN, V
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1983, 86 (02): : 180 - 185
  • [9] Further evidence for preoperative chemoradiotherapy and transanal endoscopic surgery (TEM) in T2-3s,N0,M0 rectal cancer
    Pericay, C.
    Serra-Aracil, X.
    Ocana-Rojas, J.
    Mora-Lopez, L.
    Dotor, E.
    Casalots, A.
    Pisa, A.
    Saigi, E.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (07): : 666 - 671
  • [10] Further evidence for preoperative chemoradiotherapy and transanal endoscopic surgery (TEM) in T2-3s,N0,M0 rectal cancer
    C. Pericay
    X. Serra-Aracil
    J. Ocaña-Rojas
    L. Mora-López
    E. Dotor
    A. Casalots
    A. Pisa
    E. Saigí
    [J]. Clinical and Translational Oncology, 2016, 18 : 666 - 671
12345